StockData
LeonaBio, Inc. logo

LeonaBio, Inc. (LONA) stock

LONANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$2.65−0.11 (-3.99%)

Close on Nov 18, 2026Market cap $24.97MP/E –Yield –

LeonaBio enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

LeonaBio's enterprise value was -$14.51M on Nov 11, 2026, against -$8.07M a year earlier. Over the last 5 years it ranged from -$148.77M to $250.91M, with a median of -$35.24M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026-$14.51M-413.5%
2025Dec 31, 2025$4.63M–
2024Dec 31, 2024-$46.17M–
2023Dec 29, 2023-$80.48M–
2022Dec 30, 2022-$101.08M-140.3%
2021Dec 31, 2021$250.91M-70.1%
2020Dec 31, 2020$838.47M–

More LeonaBio figures

See a number that looks wrong?